-
Major trials in coronary intervention from 2018Patel A, Marah N, Balan P et al. -
Left Ventricular Assist Device as a Bridge to Recovery for Patients With Advanced Heart FailureJakovljevic DG, Yacoub MH, Schueler S et al.
-
LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and ModulationPothineni NVK, Karathanasis SK, Mehta JL et al.
-
Cardiac Sympathetic Denervation for Refractory Ventricular ArrhythmiasM. Vaseghi, K. Shivkumar et al
-
The Aging Cardiovascular System: Understanding It at the Cellular and Clinical LevelsPaneni F, Diaz Cañestro C, Camici GG et al.
-
Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution: Part 3 of a 3-Part SeriesNiemann B, Newby DE, Kovacic JC et al.
-
Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance DocumentE Spitzer, E Mc Fadden, P Vranckx et al.
-
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trialDC Wheeler, BV Stefánsson, DAPA-CKD Trial Committees and Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
